Yuyu Pharma (000220) — Capital Reinvestment Ratio
Yuyu Pharma (000220) has a Capital Reinvestment Ratio of 1.75x as of September 2025, meaning it reinvests 2% of its operating cash flow (₩836.62 Million) in capital expenditures (₩1.46 Billion). Check 000220 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Yuyu Pharma Capital Reinvestment Ratio (2011–2024)
This chart tracks Yuyu Pharma's Capital Reinvestment Ratio across 10 annual periods. For the full cash flow conversion analysis, see how efficiently does Yuyu Pharma generate cash.
Annual Capital Reinvestment Ratio for Yuyu Pharma (2011–2024)
Year-by-year Capital Reinvestment Ratio for Yuyu Pharma from 2011 to 2024. See free cash flow generation of Yuyu Pharma to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.29x | ₩24.95 Billion | ₩7.30 Billion | ▼ -97.6% |
| 2023 | 12.13x | ₩420.86 Million | ₩5.11 Billion | ▲ +800.7% |
| 2021 | 1.35x | ₩4.51 Billion | ₩6.07 Billion | ▲ +120.5% |
| 2019 | 0.61x | ₩13.19 Billion | ₩8.06 Billion | ▼ -61.8% |
| 2018 | 1.60x | ₩6.11 Billion | ₩9.76 Billion | ▼ -82.7% |
| 2017 | 9.25x | ₩561.35 Million | ₩5.19 Billion | ▲ +3819.4% |
| 2016 | 0.24x | ₩9.82 Billion | ₩2.32 Billion | ▼ -20.4% |
| 2014 | 0.30x | ₩1.36 Billion | ₩404.37 Million | ▲ +139.8% |
| 2012 | 0.12x | ₩6.51 Billion | ₩805.15 Million | ▲ +102.1% |
| 2011 | 0.06x | ₩6.67 Billion | ₩408.49 Million | — |